AGR3 and breast carcinoma: Specifically, AGR3 promotes tamoxifen resistance in breast cancer [31], SRGN is a key molecule in mediating chemoresistance and stemness in breast cancer cells [30], and PPP1R1B is involved in resistance of breast cancer cells to trastuzumab [32].